Ligand Pharmaceuticals (LGND)

P/S ratio as of November 2026 (TTM): 21.5

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.47. At the end of 2023 the company had a P/S ratio of 9.48.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	9.48	45.3%
2022	6.53	-29.93%
2021	9.31	8.57%
2020	8.58	-41.18%
2019	14.6	30.16%
2018	11.2	-45.29%
2017	20.5	5.1%
2016	19.5	-35.21%
2015	30.1	86.35%
2014	16.1	-26.59%
2013	22.0	56.36%
2012	14.1	80.84%
2011	7.77	5.16%
2010	7.39	13.73%
2009	6.50	-31.74%
2008	9.52	-73.03%
2007	35.3	142.56%
2006	14.6	192.86%
2005	4.97	-7.18%
2004	5.36	-29.68%
2003	7.62	91.88%
2002	3.97	-71.82%
2001	14.1

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.84	-68.25%	🇺🇸 USA
Pfizer PFE	2.64	-87.74%	🇺🇸 USA
Eli Lilly LLY	14.6	-32.38%	🇺🇸 USA
Amgen AMGN	6.59	-69.42%	🇺🇸 USA
Baxter BAX	1.19	-94.49%	🇺🇸 USA
Merck MRK	5.50	-74.47%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.56	-88.12%	🇺🇸 USA
GSK plc GSK	2.31	-89.26%	🇬🇧 UK
Spectrum Pharmaceuticals SPPI	8.22	-61.86%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of November 2026 (TTM): 21.5